Clinical Trials Directory

Trials / Completed

CompletedNCT05490459

Jewel Electrophysiology (EP) Lab Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
18 (actual)
Sponsor
Element Science, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Single arm open label evaluation of the Jewel Patch Wearable Cardioverter Defibrillator (P-WCD) defibrillation waveform in adult cardiac patients.

Detailed description

The primary objective of this study is to demonstrate safety and clinical effectiveness of the Jewel, using a single transthoracic defibrillation shock to terminate life-threatening VT or VF.

Conditions

Interventions

TypeNameDescription
DEVICEJewel Patch Wearable Cardioverter Defibrillator (P-WCD)Automatic external cardioverter defibrillator that monitors patients at risk for SCA and provides a therapeutic shock if needed.

Timeline

Start date
2018-11-27
Primary completion
2021-10-07
Completion
2024-04-17
First posted
2022-08-05
Last updated
2025-01-06
Results posted
2025-01-06

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT05490459. Inclusion in this directory is not an endorsement.